Five Prime Therapeutics reported $45K in Ordinary Share Capital for its fourth fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Amgen AMGN:US $ 31989M 112M
Astrazeneca AZN:US $ 387M 59M
AstraZeneca AZN:LN 387M 59M
Bristol Myers Squibb BMY:US $ 292M 0M
Clovis Oncology CLVS:US $ 0.13M 0.01M
Cytokinetics CYTK:US $ 0.08M 0.01M
Daiichi Sankyo 4568:JP Y 50000M 0M
Eli Lilly And LLY:US $ 598.2M 0.1M
GlaxoSmithKline GSK:LN 1347M 0M
Glaxosmithkline GSK:US $ 1347M 0M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Ironwood Pharmaceuticals IRWD:US $ 0.16M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Macrogenics MGNX:US $ 0.61M 0.01M
Novartis NVS:US $ 901M 12M
Novartis NOVN:VX SF 901M 12M
Sangamo Biosciences SGMO:US $ 1.46M 0M
Xencor XNCR:US $ 0.58M 0M
Ziopharm Oncology ZIOP:US $ 0.22M 0M